The Joint Accelerator Conferences Website (JACoW) is an international collaboration that publishes the proceedings of accelerator conferences held around the world.
TY - CONF AU - Wu, X. AU - Alt, D.M. AU - Blosser, G.F. AU - Horner, G.S. AU - Neville, Z.S. AU - Paquette, J.M. AU - Usher, N.R. AU - Vincent, J.J. ED - Boland, Mark ED - Tanaka, Hitoshi ED - Button, David ED - Dowd, Rohan ED - Schaa, Volker RW ED - Tan, Eugene TI - Recent Progress in R&D for Ionetix Ion-12SC Superconducting Cyclotron for Production of Medical Isotopes J2 - Proc. of IPAC2019, Melbourne, Australia, 19-24 May 2019 CY - Melbourne, Australia T2 - International Particle Accelerator Conference T3 - 10 LA - english AB - The Ion-12SC is a sub-compact, 12.5 MeV proton su-perconducting isochronous cyclotron for commercial medical isotope production recently developed at Ionetix Corporation [1]. The machine features a patented cold steel and cryogen-free conduction cooling magnet, a low power internal cold-cathode PIG ion source, and an inter-nal liquid target [2]. It was initially designed to produce N-13 ammonia for dose on-demand cardiology applica-tions but can also be used to produce F-18, Ga-68 and other medical isotopes widely used in Positron Emission Tomography (PET). The 1st engineering prototype was completed and commissioned in September 2015, and four additional units have been completed since [3]. The first two units have been installed and operated at the University of Michigan and MIT. R&D efforts in physics and engineering have continued to improve machine performance, stability and reliability. These improve-ments include: 1) Water cooling added to the dummy dee to limit the operating temperature of the ion source to improve lifetime and performance, 2) Magnetic field maps, obtained with a Hall probe based mapper, were used to accurately measure the isochronism and provide information needed to compensate for any unwanted 1st harmonics and 3) Feedback based control methods ap-plied to regulate the beam intensity on target by adjusting the ion source cathode current. The C1 unit installed at the University of Michigan Medical School early this year treated ~100 patients/month with N-13 ammonia. The machines are now capable of routinely producing > 21 doses/day with > 99% availability. The Ionetix manu-facturing facility is capable of producing up to 30 ma-chines per year. PB - JACoW Publishing CP - Geneva, Switzerland SP - 3568 EP - 3570 KW - cyclotron KW - ion-source KW - target KW - controls KW - cathode DA - 2019/06 PY - 2019 SN - 978-3-95450-208-0 DO - DOI: 10.18429/JACoW-IPAC2019-THPMP052 UR - http://jacow.org/ipac2019/papers/thpmp052.pdf ER -